Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD.
DeepScribe Now Available on AWS Marketplace for Streamlined Clinical Documentation
What You Should Know: – DeepScribe, a leading company in ambient AI for clinical documentation, announced today the general availability of its platform on AWS